Skip to main content

I am immune to Covid-19, says Trump

By Unknown


US President Donald Trump on Sunday declared himself immune from Covid-19 as he prepares to return to the campaign trail in a fight to regain ground against surging White House rival Joe Biden.

"It looks like I'm immune for, I don't know, maybe a long time and maybe a short time, it could be a lifetime, nobody really knows, but I'm immune," Trump said in a Fox News interview, a day after his doctor affirmed he was


"You have a president who is immune... so now you have a president who doesn't have to hide in a basement like his opponent," he added -- in a jab at the Democrat Biden and his far more cautious approach to campaigning in a pandemic.

It is not yet clear to what degree contracting Covid-19 confers immunity from future infection, with early studies suggesting a few months while newer ones have indicated it could last longer


While it acknowledges that -- generally -- a person who recovers from a viral infection is protected against new infection, the World Health Organization cautioned in August: "For COVID-19, we do not yet have enough data to confirm if antibodies protect, what antibody levels are required, or how long protection will last."

During his phone interview on Fox News, Trump went on to suggest that his White House rival could himself be sick.


"If you look at Joe, he was coughing yesterday horribly and grabbing his mask, as he's coughing," Trump said. "And I don't know what that was all about, and it didn't get much press."

The Biden campaign has been publishing daily coronavirus tests for their candidate since Trump tested positive on October 1 -- landing him in hospital for three nights and derailing his campaign.

There has been less transparency surrounding Trump's own state of health, with his medical team repeatedly refusing to say when he lasted tested negative for the virus. That has fueled suspicions that he may not have been tested for several days prior to his diagnosis.

Trump rallied hundreds of supporters for a comeback event at the White House on Saturday, and is planning back-to-back rallies this week in a bit to salvage his struggling campaign three weeks from the November 3 election.

Comments

Post a Comment

Popular posts from this blog

Increased risks of drop out for women and girls : CoronaVirus Updates

By Unknown
The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...
Post a Comment
Read more

No significant benefit of Umifenovir in COVID-19 treatment: Glenmark

By Unknown
Drug firm  Glenmark Pharmaceuticals  on Friday said the addition of  antiviral Umifenovir  did not demonstrate any significant clinical benefit over  Favipiravir  alone in  moderate COVID-19 patients .  The  clinical study  evaluated the possible superiority of the combination's efficacy against Favipiravir monotherapy, Glenmark said in a statement. As per the results that Glenmark presented to the regulator, the study showed no superior clinical outcomes with the addition of Umifenovir, it added. This was the second clinical study after the successful Favipiravir monotherapy trial earlier this year that led the company to receiving the Emergency Use Authorisation for Favipiravir, Glenmark said. "These latest findings confirm that the addition of Umifenovir does not show any incremental benefit in clinical outcomes. Thus Favipiravir therapy along with supportive care remains a suitable and effective choice for mild to moderate COVID-1...
Post a Comment
Read more

Context & pre-existing barriers to education for girls and women

By Unknown
Education is a right for all children and an educated population is essential for building a self-reliant, peaceful, equal, and inclusive Afghan society. Afghanistan’s education system has been severely impacted by decades of conflict, widespread poverty and humanitarian crisis.  Today, funding remains insufficient, as only 3% of Afghanistan’s Gross Domestic Product is allocated to education. International standards state that the government should spend at least 4 to 6% of GDP on education.  The Incheon Declaration and Framework for Action for the implementation of Sustainable Development Goal 4 recognizes that to “ensure inclusive and equitable quality education and promote lifelong learning opportunities for all”, least developed countries need to dedicate at least or more than 4 to 6%.  Afghanistan budgets far less than this, and even with this small percentage of funding the country’s education budget continues to be underspent every year.Afghanistan has one of the y...
Post a Comment
Read more